Patents Assigned to Nugerontix Limited
  • Publication number: 20190224163
    Abstract: The present application concerns compositions comprising ellagitannins and proanthocyanidins, and the use of such compositions for preventing or treating endothelial dysfunction. The compositions of the invention comprise at least one ellagitannin in combination with at least one proanthocyanidin. The present application also concerns methods of treating, preventing, or delaying the onset of endothelial dysfunction using compositions comprising ellagitannins and proanthocyanidins.
    Type: Application
    Filed: April 2, 2019
    Publication date: July 25, 2019
    Applicant: Nugerontix Limited
    Inventor: Roger Corder
  • Patent number: 10285970
    Abstract: The present application concerns compositions comprising ellagitannins and proanthocyanidins, and the use of such compositions for preventing or treating endothelial dysfunction. The compositions of the invention comprise at least one ellagitannin in combination with at least one proanthocyanidin. The present application also concerns methods of treating, preventing, or delaying the onset of endothelial dysfunction using compositions comprising ellagitannins and proanthocyanidins.
    Type: Grant
    Filed: July 24, 2015
    Date of Patent: May 14, 2019
    Assignee: Nugerontix Limited
    Inventor: Roger Corder
  • Publication number: 20170216245
    Abstract: The present application concerns polyphenol compositions, and the use of such compositions for preventing or treating endothelial dysfunction. The polyphenol compositions of the invention comprise at least one ellagitannin in combination with at least one proanthocyanidin.
    Type: Application
    Filed: July 24, 2015
    Publication date: August 3, 2017
    Applicant: Nugerontix Limited
    Inventor: Roger Corder